The Australian Incentive - a 43.5% cash-back on bioanalytical services spend
Australia offers the world’s most attractive environment for conducting clinical trials in terms of speed and cost – in addition to its leading clinical and medical sector which rivals the best internationally.
The Australian Government offers a 43.5% cash rebate on clinical trial spend including bioanalytics. This incentive program is ideal for biotech companies wanting to conserve their financial resources and biotech investors who are eyeing costs. We can let you know the process and refer you to trusted partners to make sure you get the most value.
